4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-17-061597
SVP & Chief Accounting Officer returned 5,289 shares (to the company)
- SVP & Chief Accounting Officer acquired 15,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thomsen Jillian B. SVP & Chief Accounting Officer | 2017-11-15 | Grant or award | +15,000 | 65,838 | D: show line 1 in the form | ||
| Thomsen Jillian B. SVP & Chief Accounting Officer | 2017-11-16 | Returned to the company | −5,289 | $44.23 | $233,932 | 60,549 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Thomsen Jillian B. SVP & Chief Accounting Officer | 2017-11-15 | Grant or award · Stock Option | +37,500 | 37,500 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…